Sunshine Biopharma Inc. (SBFM) Net income 2016–2025
Sunshine Biopharma Inc. (SBFM) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$6.0MFY2025 · since FY2016: -$3.5M → -$6.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$6.0M | -16.4% |
| FY2024 | -$5.1M | -13.9% |
| FY2023 | -$4.5M | +83.2% |
| FY2022 | -$26.7M | -115.0% |
| FY2021 | -$12.4M | -346.7% |
| FY2020 | -$2.8M | -67.7% |
| FY2019 | -$1.7M | +23.0% |
| FY2018 | -$2.2M | -107.3% |
| FY2017 | -$1.0M | +70.3% |
| FY2016 | -$3.5M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More SBFM financial trends
SBFM RevenueSBFM Net marginSBFM Gross profitSBFM Gross marginSBFM Operating incomeSBFM Operating marginSBFM Operating cash flowSBFM Free cash flowSBFM Capital expendituresSBFM Return on equitySBFM Stock buybacksSBFM Dividends paidSBFM Total assetsSBFM Total liabilitiesSBFM Shareholders’ equitySBFM overview →